196 related articles for article (PubMed ID: 21649638)
1. Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.
Laurila JM; Wissel G; Xhaard H; Ruuskanen JO; Johnson MS; Scheinin M
Br J Pharmacol; 2011 Nov; 164(5):1558-72. PubMed ID: 21649638
[TBL] [Abstract][Full Text] [Related]
2. Spiroxatrine derivatives towards 5-HT
Sorbi C; Tait A; Battisti UM; Brasili L
Pharmacol Rep; 2020 Apr; 72(2):427-434. PubMed ID: 32002826
[TBL] [Abstract][Full Text] [Related]
3. The second extracellular loop of alpha2A-adrenoceptors contributes to the binding of yohimbine analogues.
Laurila JM; Xhaard H; Ruuskanen JO; Rantanen MJ; Karlsson HK; Johnson MS; Scheinin M
Br J Pharmacol; 2007 Aug; 151(8):1293-304. PubMed ID: 17558432
[TBL] [Abstract][Full Text] [Related]
4. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Jahnsen JA; Uhlén S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1031-40. PubMed ID: 23868076
[TBL] [Abstract][Full Text] [Related]
5. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M
J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
Piletz JE; Zhu H; Chikkala DN
J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
[TBL] [Abstract][Full Text] [Related]
7. Characterization of α(2B)-adrenoceptor ligand binding in the presence of muscarinic toxin α and delineation of structural features of receptor binding selectivity.
Näreoja K; Näsman J
Eur J Pharmacol; 2012 May; 683(1-3):63-70. PubMed ID: 22465183
[TBL] [Abstract][Full Text] [Related]
8. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands.
Bavadekar SA; Hong SS; Lee SI; Miller DD; Feller DR
Eur J Pharmacol; 2008 Aug; 590(1-3):53-60. PubMed ID: 18589415
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of alpha 2-adrenoceptors in human and rat myometrium and differential expression during pregnancy.
Bouet-Alard R; Mhaouty-Kodja S; Limon-Boulez I; Coudouel N; Maltier JP; Legrand C
Br J Pharmacol; 1997 Dec; 122(8):1732-8. PubMed ID: 9422821
[TBL] [Abstract][Full Text] [Related]
10. The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors.
Uhlén S; Porter AC; Neubig RR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1558-65. PubMed ID: 7996470
[TBL] [Abstract][Full Text] [Related]
11. Conserved structural, pharmacological and functional properties among the three human and five zebrafish alpha 2-adrenoceptors.
Ruuskanen JO; Laurila J; Xhaard H; Rantanen VV; Vuoriluoto K; Wurster S; Marjamäki A; Vainio M; Johnson MS; Scheinin M
Br J Pharmacol; 2005 Jan; 144(2):165-77. PubMed ID: 15655522
[TBL] [Abstract][Full Text] [Related]
12. [The alpha-antiadrenergic properties of spiroxatrine, a ligand of serotonergic 5-HT1A receptors].
Terrón JA; Ibarra M; Ransanz V; Hong E; Villalón CM
Arch Inst Cardiol Mex; 1993; 63(4):289-95. PubMed ID: 8105762
[TBL] [Abstract][Full Text] [Related]
13. Molecular modelling of subtypes (alpha(2A), alpha(2B) and alpha(2C)) of alpha(2)-adrenoceptors: a comparative study.
Balogh B; Szilágyi A; Gyires K; Bylund DB; Mátyus P
Neurochem Int; 2009 Nov; 55(6):355-61. PubMed ID: 19447153
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the postjunctional alpha 2C-adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins.
Görnemann T; von Wenckstern H; Kleuser B; Villalón CM; Centurión D; Jähnichen S; Pertz HH
Br J Pharmacol; 2007 May; 151(2):186-94. PubMed ID: 17375080
[TBL] [Abstract][Full Text] [Related]
15. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
[TBL] [Abstract][Full Text] [Related]
16. Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype.
MacLennan SJ; Luong LA; Jasper JR; To ZP; Eglen RM
Br J Pharmacol; 1997 Aug; 121(8):1721-9. PubMed ID: 9283709
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the binding activities of some drugs on alpha 2A, alpha 2B and alpha 2C-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig.
Uhlén S; Muceniece R; Rangel N; Tiger G; Wikberg JE
Pharmacol Toxicol; 1995 Jun; 76(6):353-64. PubMed ID: 7479575
[TBL] [Abstract][Full Text] [Related]
18. Ligand modulation of [35S]GTPgammaS binding at human alpha(2A), alpha(2B) and alpha(2C) adrenoceptors.
Audinot V; Fabry N; Nicolas JP; Beauverger P; Newman-Tancredi A; Millan MJ; Try A; Bornancin F; Canet E; Boutin JA
Cell Signal; 2002 Oct; 14(10):829-37. PubMed ID: 12135704
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.
Peltonen JM; Nyrönen T; Wurster S; Pihlavisto M; Hoffrén AM; Marjamäki A; Xhaard H; Kanerva L; Savola JM; Johnson MS; Scheinin M
Br J Pharmacol; 2003 Sep; 140(2):347-58. PubMed ID: 12970108
[TBL] [Abstract][Full Text] [Related]
20. The roles of alpha2-adrenoceptor subtypes in the control of cervical resistance in the late-pregnant rat.
Gál A; Ducza E; Minorics R; Klukovits A; Gálik M; Falkay G; Gáspár R
Eur J Pharmacol; 2009 Aug; 615(1-3):193-200. PubMed ID: 19450576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
